MESOTHELIOMA
Clinical trials for MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink advanced mesothelioma tumors
Disease control Not yet recruitingThis study tests whether adding two experimental drugs (iparomlimab and tovorilimab) to standard chemotherapy and bevacizumab can shrink tumors in people with advanced mesothelioma who have not had prior treatment. About 37 adults aged 18-75 will receive the combination and be mo…
Matched conditions: MESOTHELIOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
New hope for mesothelioma patients: targeted drug aims to shrink tumors
Disease control Not yet recruitingThis study tests a drug called BMS-986504 in people with a type of mesothelioma that has returned after initial treatment. It is for patients whose tumors have a specific genetic change (MTAP deficiency). The goal is to see if the drug can shrink tumors or stop them from growing.…
Matched conditions: MESOTHELIOMA
Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control
Last updated May 26, 2026 03:21 UTC
-
Experimental cell therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage study tests a new cell therapy called KT032 in 24 adults with advanced solid tumors (ovarian, mesothelioma, or colon cancer) that have spread in the belly. The main goals are to check safety and find the best dose. Participants must have tried standard treatments…
Matched conditions: MESOTHELIOMA
Phase: EARLY_PHASE1 • Sponsor: Weijia Fang, MD • Aim: Disease control
Last updated May 26, 2026 03:16 UTC